GUDIDData
eudamed_udi Primary ID: D-01001DP

GA-map® Dysbiosis Test Lx v2 (UDI D-01001DP)

Manufactured by Genetic Analysis AS

Data verified against official FDA/EUDAMED records on
Scannable UDI-DI Representation
GS1-128 UDI Barcode representation for GA-map® Dysbiosis Test Lx v2 - Primary ID D-01001DP

Device Regulatory Overview

The GA-map® Dysbiosis Test Lx v2 (Model/Catalog Number: 1001) is a medical device manufactured by Genetic Analysis AS. This product is indexed under FDA Product Code / Category Classification W010699 within international Unique Device Identification (UDI) compliance databases.

Technical Specifications

Model Number
1001
Product Code / EMDN
W010699
Device Name
GA-map® Dysbiosis Test Lx v2
Database Sync Date
2026-08-09 17:29:10

Full Regulatory Attributes

🔒 Token Gated
{
    "review_panel": "AN",
    "gudid_di_status": "Published",
    "sterilization_methods": ["EO", "Gamma"],
    "rx_only": true
}
                            

Unlock Compliance Data & Serialization Specs

Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.

Get API Token Access ($49/mo)

Frequently Asked Questions

Who is the primary manufacturer of GA-map® Dysbiosis Test Lx v2?

The registered manufacturer of record for GA-map® Dysbiosis Test Lx v2 is Genetic Analysis AS.

What is the Primary UDI-DI identifier for GA-map® Dysbiosis Test Lx v2?

The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is D-01001DP.

What classification code is assigned to this device?

This device is registered under product classification code W010699.

Programmatic Export

Export this master device record as standardized JSON or CSV for compliance audits.

JSON API Endpoint